Abstract | BACKGROUND AND AIM: The infusion of chronic angiotensin II (Ang II) has been shown to promote renal interstitial fibrosis. To evaluate the pathophysiological significance of the natriuretic peptide-GC-A system, we infused Ang II (1.0 mg/kg/day) in GC-A-deficient mice (GC-A-KO). METHODS: We used 5 groups (Wild-Saline n = 12, Wild-Ang II n = 14, GC-A-KO-Saline n = 11, GC-A-KO-Ang II n = 13, and GC-A-KO-Ang II- Hydralazine n = 10). Saline or Ang II was infused subcutaneously using an osmotic minipump for 3 weeks. Hydralazine was administered orally (0.05 g/L in drinking water). RESULTS: Systolic blood pressure was significantly higher in the GC-A-KO-Saline group (130 ± 12 mmHg) than in the Wild-Saline group (105 ± 30 mmHg), and was similar to that in the Wild-Ang II (141 ± 17 mmHg) and GC-A-KO-Ang II- Hydralazine (140 ± 20 mmHg) groups. Systolic blood pressure was significantly higher in the GC-A-KO-Ang II group (159 ± 21 mmHg) than in the 4 other groups. Renal tubular atrophy and interstitial fibrosis were significantly more severe in the GC-A-KO-Ang II group ( atrophy 13.4 %, fibrosis 12.0 %) than in the Wild-Saline (0, 2.0 %), Wild-Ang II (2.9, 4.4 %), and GC-A-KO-Saline (0, 2.6 %) groups. Hydralazine could not inhibit this aggravation (GC-A-KO-Ang II- Hydralazine 13.5, 11.3 %). The expression of monocyte chemotactic protein-1 in tubular cells, and F4/80 and alpha-smooth muscle actin in the interstitium was clearly detected in the Ang II-infused wild and GC-A-KO groups and was associated with renal tubular atrophy and interstitial fibrosis. The expression of E-cadherin in tubular cells was absent in the Ang II-infused wild and GC-A-KO groups and was associated with renal tubular atrophy. CONCLUSIONS: The natriuretic peptide-GC-A system may play an inhibitory role in Ang II-induced renal tubular atrophy, interstitial fibrosis, and phenotypic transformation in renal tubular cells and fibroblasts.
|
Authors | Fumiki Yoshihara, Takeshi Tokudome, Ichiro Kishimoto, Kentaro Otani, Atsunori Kuwabara, Takeshi Horio, Yuhei Kawano, Kenji Kangawa |
Journal | Clinical and experimental nephrology
(Clin Exp Nephrol)
Vol. 19
Issue 2
Pg. 197-207
(Apr 2015)
ISSN: 1437-7799 [Electronic] Japan |
PMID | 24845230
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Actins
- Antigens, Differentiation
- Antihypertensive Agents
- Cadherins
- Chemokine CCL2
- Intracellular Signaling Peptides and Proteins
- Membrane Proteins
- NPHS2 protein
- RNA, Messenger
- Vasoconstrictor Agents
- alpha-smooth muscle actin, mouse
- monocyte-macrophage differentiation antigen
- Osteopontin
- Angiotensin II
- Hydralazine
- Sodium Chloride
- Receptors, Atrial Natriuretic Factor
- atrial natriuretic factor receptor A
|
Topics |
- Actins
(analysis)
- Angiotensin II
(pharmacology)
- Animals
- Antigens, Differentiation
(analysis, genetics)
- Antihypertensive Agents
(pharmacology)
- Atrophy
- Blood Pressure
(drug effects, genetics)
- Cadherins
(analysis)
- Chemokine CCL2
(analysis)
- Fibrosis
- Gene Expression
(drug effects)
- Hydralazine
(pharmacology)
- Intracellular Signaling Peptides and Proteins
(genetics)
- Kidney Tubules
(chemistry, pathology)
- Male
- Membrane Proteins
(genetics)
- Mice
- Mice, Knockout
- Osteopontin
(genetics)
- RNA, Messenger
(metabolism)
- Receptors, Atrial Natriuretic Factor
(deficiency, genetics)
- Sodium Chloride
(pharmacology)
- Vasoconstrictor Agents
(pharmacology)
|